Bacterial Vaginosis
📧 Sign up to get email alerts when something new happens for Bacterial Vaginosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-07-16Clinical Trial Update: Rwanda Vaginal Microbiota Restoration Study [NA]
A completed clinical trial in Rwanda studied vaginal microbiota restoration for bacterial vaginosis with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-09Clinical Trial Update: Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV) [Phase 3]
Phase 3 trial updating efficacy and safety of SPL7013 Gel to prevent BV recurrence has completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-09Clinical Trial Update: A Phase 3 Study of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis [Phase 3]
Phase 3 clinical trial of SPL7013 Gel (VivaGel) for treating bacterial vaginosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-09Clinical Trial Update: A Phase 3 Study of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis [Phase 3]
Phase 3 study of SPL7013 Gel (VivaGel) for treating bacterial vaginosis has completed with results posted.
-
FDA approval · 2019-07-02FDA Approved: METRONIDAZOLE VAGINAL — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved METRONIDAZOLE VAGINAL as an original generic application (ANDA) to manufacture a metronidazole vaginal product, with Padagis Is…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2019-06-07FDA Approved: TINDAMAX — Supplemental Application (Mission Pharmacal Company)
FDA approved a supplemental application for TINDAMAX (tinidazole) to update the labeling, including expansion of indications.
-
CLINICAL_TRIALS trial_result · 2019-06-06Clinical Trial Update: Dose Ranging Study of SPL7013 Gel for Treatment of Bacterial Vaginosis (BV) [Phase 2]
Phase 2 dose-ranging trial of SPL7013 gel for bacterial vaginosis has completed and results posted.
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Bacterial Vaginosis Screening at IUD Insertion
A clinical trial evaluating screening for bacterial vaginosis at the time of IUD insertion has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Honghe Fujie Lotion for the Treatment of Bacterial Vaginosis [Phase 4]
Phase 4 clinical trial update for Honghe Fujie Lotion in the treatment of bacterial vaginosis.
-
CLINICAL_TRIALS trial_result · 2018-12-28Clinical Trial Update: Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis [Phase 2]
Phase 2 trial assessing safety and efficacy of 5% monolaurin vaginal gel for treatment of bacterial vaginosis has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2018-12-10Clinical Trial Update: Effects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local Immunity [Phase 4]
Phase 4 trial assessing the effects of a contraceptive ring on vaginal microbiota, HIV shedding, and local immunity in bacterial vaginosis a…
-
CLINICAL_TRIALS trial_result · 2018-08-07Clinical Trial Update: Vaginal Clindamycin Cream Plus Vaginal Probiotic for Bacterial Vaginosis [Phase 2]
Phase 2 clinical trial update for vaginal clindamycin cream with a vaginal probiotic in bacterial vaginosis.
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Inflammation and Treatment of Bacterial Vaginosis Near Term [NA]
A completed clinical trial update on inflammation and treatment of bacterial vaginosis near term conducted by the Medical University of Sout…
-
CLINICAL_TRIALS trial_result · 2018-06-25Clinical Trial Update: Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV) [Phase 3]
The Phase 3 trial evaluating SPL7013 Gel to prevent recurrence of bacterial vaginosis has completed. The sponsor is Starpharma Pty Ltd.
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Bacterial Vaginosis Carriage in Early Pregnancy and Preterm Delivery in Martinique, F.W.I
A completed clinical trial in Martinique evaluated bacterial vaginosis carriage in early pregnancy and its association with preterm delivery…
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: LUXSOL(TM) Topical Cream for the Treatment of Symptomatic Bacterial Vaginosis; A Proof of Concept Study [EARLY_Phase 1]
An early Phase 1 proof-of-concept trial evaluating LUXSOL Topical Cream for symptomatic bacterial vaginosis has been terminated.
-
FDA approval · 2018-04-03FDA Approved: FLAGYL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Flagyl (metronidazole) from Pfizer Laboratories Div Pfizer Inc, resulting in changes to the …
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: TOL-463 Phase 2 Study for Vaginitis [Phase 2]
The Phase 2 study of TOL-463 for vaginitis, covering bacterial vaginosis and vulvovaginal candidiasis, has completed.
-
CLINICAL_TRIALS trial_result · 2017-12-14Clinical Trial Update: A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis [Phase 2]
A Phase 2 clinical trial update for SYM-1219 in bacterial vaginosis has completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: PreFem: "What Happens to the Vaginal Microbiota When a BV Infection is Treated With Metronidazole?" [NA]
A completed clinical trial (NCT03187457) studied how treating bacterial vaginosis with metronidazole affects the vaginal microbiota.
-
FDA approval · 2017-12-12FDA Approved: METRONIDAZOLE — Original Application (Cadila Pharmaceuticals Limited)
FDA approved Cadila Pharmaceuticals' generic metronidazole under an Original Application (ANDA209794).
-
FDA approval · 2017-12-04FDA Approved: METRONIDAZOLE — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved a supplemental application for Metronidazole from Baxter Healthcare Corporation, typically reflecting labeling updates or o…
-
CLINICAL_TRIALS research · 2017-12-02Clinical Trial Update: Clinical Study to Evaluate the Efficacy of HUDC_VT in Patients With Bacterial Vaginosis [Phase 2]
A Phase 2 clinical trial update evaluating HUDC_VT for bacterial vaginosis, sponsored by Haudongchun Co., Ltd., with the study status curren…
-
FDA approval · 2017-09-15FDA Approved: SOLOSEC — Original Application (Evofem Inc.)
FDA approved SOLOSEC (secnidazole) under Evofem Inc.'s original NDA for the treatment of bacterial vaginosis.
-
FDA approval · 2017-09-05FDA Approved: METRONIDAZOLE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for METRONIDAZOLE from Aurobindo Pharma Limited (ANDA 203974).